Powell, JT; Sweeting, MJ; Ulug, P; Blankensteijn, JD; Lederle, FA; Becquemin, J-P; Greenhalgh, RM; EVAR-1, DREAM, OVER and ACE Trialists
(2017)
Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years.
Br J Surg, 104 (3).
pp. 166-178.
ISSN 1365-2168
https://doi.org/10.1002/bjs.10430
SGUL Authors: Morgan, Robert Anthony
|
PDF
Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (677kB) | Preview |
|
![]() |
Microsoft Word (.docx) (Supplementary data)
Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (947kB) |
Abstract
BACKGROUND: The erosion of the early mortality advantage of elective endovascular aneurysm repair (EVAR) compared with open repair of abdominal aortic aneurysm remains without a satisfactory explanation. METHODS: An individual-patient data meta-analysis of four multicentre randomized trials of EVAR versus open repair was conducted to a prespecified analysis plan, reporting on mortality, aneurysm-related mortality and reintervention. RESULTS: The analysis included 2783 patients, with 14 245 person-years of follow-up (median 5·5 years). Early (0-6 months after randomization) mortality was lower in the EVAR groups (46 of 1393 versus 73 of 1390 deaths; pooled hazard ratio 0·61, 95 per cent c.i. 0·42 to 0·89; P = 0·010), primarily because 30-day operative mortality was lower in the EVAR groups (16 deaths versus 40 for open repair; pooled odds ratio 0·40, 95 per cent c.i. 0·22 to 0·74). Later (within 3 years) the survival curves converged, remaining converged to 8 years. Beyond 3 years, aneurysm-related mortality was significantly higher in the EVAR groups (19 deaths versus 3 for open repair; pooled hazard ratio 5·16, 1·49 to 17·89; P = 0·010). Patients with moderate renal dysfunction or previous coronary artery disease had no early survival advantage under EVAR. Those with peripheral artery disease had lower mortality under open repair (39 deaths versus 62 for EVAR; P = 0·022) in the period from 6 months to 4 years after randomization. CONCLUSION: The early survival advantage in the EVAR group, and its subsequent erosion, were confirmed. Over 5 years, patients of marginal fitness had no early survival advantage from EVAR compared with open repair. Aneurysm-related mortality and patients with low ankle : brachial pressure index contributed to the erosion of the early survival advantage for the EVAR group. Trial registration numbers: EVAR-1, ISRCTN55703451; DREAM (Dutch Randomized Endovascular Aneurysm Management), NCT00421330; ACE (Anévrysme de l'aorte abdominale, Chirurgie versus Endoprothèse), NCT00224718; OVER (Open Versus Endovascular Repair Trial for Abdominal Aortic Aneurysms), NCT00094575.
Item Type: | Article | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Additional Information: | © 2017 The Authors. BJS published by John Wiley & Sons Ltd on behalf of BJS Society Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com | ||||||||||||
Keywords: | Aged, Aged, 80 and over, Aortic Aneurysm, Abdominal, Elective Surgical Procedures, Endovascular Procedures, Female, Humans, Male, Middle Aged, Models, Statistical, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Reoperation, Treatment Outcome, Vascular Grafting, EVAR-1, DREAM, OVER and ACE Trialists, Humans, Aortic Aneurysm, Abdominal, Treatment Outcome, Reoperation, Models, Statistical, Aged, Aged, 80 and over, Middle Aged, Female, Male, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Endovascular Procedures, Vascular Grafting, Elective Surgical Procedures, 11 Medical and Health Sciences, Surgery | ||||||||||||
SGUL Research Institute / Research Centre: | Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) | ||||||||||||
Journal or Publication Title: | Br J Surg | ||||||||||||
ISSN: | 1365-2168 | ||||||||||||
Language: | eng | ||||||||||||
Dates: |
|
||||||||||||
Publisher License: | Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0 | ||||||||||||
Projects: |
|
||||||||||||
PubMed ID: | 28160528 | ||||||||||||
Web of Science ID: | WOS:000393597100002 | ||||||||||||
Go to PubMed abstract | |||||||||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/114642 | ||||||||||||
Publisher's version: | https://doi.org/10.1002/bjs.10430 |
Statistics
Actions (login required)
![]() |
Edit Item |